'This health emergency has brought a lot of people together with the common purpose of getting Feluda to play detective as quickly as possible.''As a scientist, if we can make a small difference in......
Three sectors – pharma, high tech and consumer products – are projected to spur salary growth in India as they are expected to perform relatively better and offer better hikes.......
Campus placements are already in full-swing and hiring plans of many companies, whose expansion plans were stuck due to policy paralysis, are now getting green signals. Image: A recruiter for......
The rising regulatory hurdles for Indian pharmaceutical companies in the US could prove a blessing for American generic medicine manufacturers. While leading Indian drug makers are increasingly......
A new drug price control policy at long last, restrictions on multinationals taking over domestic firms and India cracking down on foreign firms' patents marked the year 2012 for the country's $22......
The upside for Ranbaxy Laboratories is likely to continue even as it loses its 180 days of marketing exclusivity for the Lipitor generic in the American market.While Teva recently withdrew plans to......